The promise of genome editing to help understand human diseases and create new therapies is vast, but technological ...

Scientists from the National University of Singapore (NUS) have developed NAPTUNE (Nucleic Acids and Protein biomarkers ...

Learn about how researchers in Florida are using CRISPR gene editing technology to build disease-resistant orange trees ...

A new study from the Norwegian Institute of Food, Fisheries, and Aquaculture Research (Nofima) has analyzed different salmon ...

LLY's move to buy Verve ignites investor interest across gene-editing stocks like CRSP, NTLA and BEAM in a booming M&A year.

Zacks.com users have recently been watching CRISPR Therapeutics (CRSP) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

The acquisition aligns with Eli Lilly’s broader diversification strategy beyond its core diabetes and obesity treatment ...

With the new method, that is changing. The research team was able to analyze 54 previously unclear BRCA2 variants and ...

For his DC-PGE project (DNA-binding domain Conditioned Precision Genome Editing), Prof. Frank Buchholz has been awarded an Advanced Grant from the European Research Council (ERC), the highest endowed ...

A groundbreaking method developed in Denmark could give thousands worldwide the answer they never thought they’d get. The ...

Baker Brothers’ Q1 2025 portfolio reveals biotech investment trends. See more on their top holdings, stake changes, and ...

One way would be to ensure there is a consistent and predictable yield year by year. For two years in a row, beginning in the ...